Investment
Features
FeesSafety
Academy
More
Pluang+

C&C Group acquires Asahi UK's wholesale businesses, expanding Matthew Clark Bibendum's reach.

Company Fundamentals
11 Sep 2026
Proactive Investors
View Source
Bullish
C&C Group acquires Asahi UK's wholesale businesses, expanding Matthew Clark Bibendum's reach.

C&C Group PLC has agreed to acquire Asahi UK's wholesale businesses, including Nectar Imports and Asahi UK's direct distribution operations, for a nominal fee. This acquisition will expand C&C's Matthew Clark Bibendum operation by adding a significant new customer base and integrating supply arrangements for the Fuller, Smith & Turner pub estate. The deal includes customer and supplier relationships, intellectual property, a leased depot, vehicles, and stock. C&C expects the transaction to complete by early October and forecasts a small positive contribution to Matthew Clark Bibendum's performance for the year ending February 2027. Separately, C&C reported stable trading for the six months to August 31, with a slight decline in group net revenue but growth in branded revenue driven by key brands like Tennent’s, Bulmers, and Innis & Gunn.

More News

GE Aerospace Q3 earnings expected to show strong growth amid high investor expectations.

GE Aerospace Q3 earnings expected to show strong growth amid high investor expectations.

GE Aerospace is set to report its Q3 earnings with analysts forecasting a 21.7% rise in earnings per share to $2.02 and nearly 12% revenue growth to about $12.7 billion. Despite consistently beating estimates, the stock has fallen after past reports ...

Company Fundamentals
Neutral
12 minutes ago
Silence Therapeutics jumps 125% after $1.3B acquisition deal with Merck KGaA

Silence Therapeutics jumps 125% after $1.3B acquisition deal with Merck KGaA

Silence Therapeutics' stock surged 125.6% to $19.58 following Merck KGaA's agreement to acquire the RNA-interference drug developer for about $1.3 billion in equity value. Merck will pay $20 per share, a 130% premium over the recent closing price. Ot...

Market News
Bullish
12 minutes ago
Stocks tumble as Iambic Therapeutics and TCGX Acquisition lead losses amid IPO and merger news.

Stocks tumble as Iambic Therapeutics and TCGX Acquisition lead losses amid IPO and merger news.

On October 19, 2026, several stocks saw significant declines. Iambic Therapeutics dropped 31.4% but stayed just above its IPO price of $16 after raising $150 million. TCGX Acquisition fell 18.5% following its announcement of a merger with TriGemX Bio...

Market News
Bearish
12 minutes ago
Trading resumes for GoldCoast Resource Corp. on Canadian markets after regulatory halt.

Trading resumes for GoldCoast Resource Corp. on Canadian markets after regulatory halt.

Trading in all issues of GoldCoast Resource Corp. (symbol GCR) has resumed at 8:00 AM ET following a temporary halt imposed by the Canadian Investment Regulatory Organization (CIRO). Such halts are used to maintain fair and orderly markets. CIRO over...

Market News
Neutral
24 minutes ago
Equity Bancshares director buys shares amid strong Q3 earnings and dividend hike

Equity Bancshares director buys shares amid strong Q3 earnings and dividend hike

Equity Bancshares director Leon Borck increased his stake by purchasing 380 shares at $48.78 each, signaling confidence after the company reported strong Q3 results. The bank posted a net income of $26.8 million and core earnings of $1.40 per diluted...

Market News
Bullish
57 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App